Immunovant Stock Investor Trims Stake, Still Bullish
Immunovant stock surged about 30% after a fund trimmed its stake by roughly $3 million. This article explains why the...
Life events or new priorities often require tweaks; identify triggers and implement targeted changes to keep your finances on track.
19,621 articlesImmunovant stock surged about 30% after a fund trimmed its stake by roughly $3 million. This article explains why the...
As the Nasdaq pauses, history suggests a potential rebound. This guide dives into two high-growth stocks poised to ri...
Oracle isn't done spending on AI, and the move is shaking up how investors view cloud growth and profitability. This ...
An executive sale of shares often sparks questions. This article unpacks what cheesecake factory sells $328000 means ...
A fintech stock surged in recent years, then faced a pullback during down weeks. This article outlines a disciplined ...
A clear, practical guide to reading a 2026 earnings transcript. Learn which numbers matter, how management commentary...
Himax (HIMX) faces a pivotal year as AR/VR, automotive displays, and smartphone drivers shape demand. This Q1 2026 ea...
A major fund sold almost 230k ANIP shares in Q1, triggering volatility in the pharma stock. This article breaks down ...
Powell's departure marks more than a leadership change. A divided FOMC and a market still riding AI-driven highs crea...
A notable fund exited a sizable stake in Huron Consulting Group, locking in gains and signaling a disciplined approac...
If you're weighing two ad-tech stocks, this guide breaks down how to think about should zeta global stock versus AppL...
A fresh recession signal has appeared. This guide breaks down what it means and outlines concrete steps you can take ...